Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy

Overview of attention for article published in BMC Cancer, April 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,749 followers.

RT @fdinicolantonio: Complete response to #BRAF inhibitor #vemurafenib in a BRAF mutant pediatric glioblastoma patient http://t.co/flmredQf…

Complete response to #BRAF inhibitor #vemurafenib in a BRAF mutant pediatric glioblastoma patient http://t.co/flmredQfwX

Complete clinical regression of a BRAF V600E-mutant pediatric #glioblastoma multiforme after BRAF inhibitor therapy http://t.co/QRv8IY2vy8

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.